Illness	Number of cases
Heart failure (I50.01)	243
Cerebral infarction (I63.4)	149
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	130
Cystitis (N30.0)	84
Volume depletion (E86)	67
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	64
Other transient cerebral ischemic attacks and related syndromes (G45.82)	59
Unspecified acute lower respiratory infection (J22)	59
Essential primary hypertension (I10.01)	53
Gastritis and duodenitis (K29.1)	48

Top 10 treatments

Treatment	Number
Computed tomography (CT) of the head without contrast medium (3-200)	976
Anaesthesia with administration of an anaesthetic into a vein (8-900)	964
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	469
(9-984.7)	364
(9-984.8)	330
Computed tomography of the head with contrast medium (3-220)	282
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.a)	279
Computed tomography of the neck with contrast medium (3-221)	242
Ultrasound of the heart (echocardiography) through the oesophagus - TEE (3-052)	213
Computed tomography (CT) of the chest without contrast medium (3-202)	209

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
33	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
19	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility